Cargando…
Evaluating the Role of the Interleukin-23/17 Axis in Critically Ill COVID-19 Patients
Studies have hypothesized a potential role of the interleukin (IL)-23/17 axis in coronavirus disease 2019 (COVID-19). However, to date, levels of IL-23 and 17 have not been compared between critically ill COVID-19 patients and critically ill non-COVID-19 patients. IL-23 and 17 were measured on admis...
Autores principales: | Jahaj, Edison, Vassiliou, Alice G., Keskinidou, Chrysi, Gallos, Parisis, Vrettou, Charikleia S., Tsipilis, Stamatios, Mastora, Zafeiria, Orfanos, Stylianos E., Dimopoulou, Ioanna, Kotanidou, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466794/ https://www.ncbi.nlm.nih.gov/pubmed/34575667 http://dx.doi.org/10.3390/jpm11090891 |
Ejemplares similares
-
Lactate and Lactate-to-Pyruvate Ratio in Critically Ill COVID-19 Patients: A Pilot Study
por: Vassiliou, Alice G., et al.
Publicado: (2022) -
Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis
por: Vassiliou, Alice G., et al.
Publicado: (2022) -
Investigation of Serum Endocan Levels and Age in Critical Inflammatory Conditions
por: Keskinidou, Chrysi, et al.
Publicado: (2023) -
ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
por: Vassiliou, Alice G., et al.
Publicado: (2021) -
Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone
por: Keskinidou, Chrysi, et al.
Publicado: (2021)